Private Equity & Venture Capital
Fund strategy, co-investment programme design, GP selection, and the structural dynamics reshaping private capital deployment for sovereign allocators.
The Paradox of Abundance
Dry powder exceeding $2.5 trillion signals not strength but a structural deployment bottleneck. GPs raised aggressively during the low-rate era of 2019-2022, and subsequent rate tightening exposed a fundamental mismatch between fund vintages and investable deal flow at acceptable entry multiples. The denominator effect forced LPs into technical overallocation. Although public market recoveries partially corrected portfolio denominators, LP caution toward new commitments persists.
Continuation vehicles — $60 billion in 2025 transactions — have become the dominant liquidity mechanism. Traditional IPO exits remain depressed. Sponsor-to-sponsor secondaries increasingly involve the same GP on both sides, raising governance questions that ILPA has only begun to address. The largest sovereigns (PIF, Mubadala, GIC, ADIA, Temasek) are accelerating from blind-pool LP commitments toward co-investment, direct investment, and GP-seeding that fundamentally alter intermediation economics.
The industry bifurcates: mega-platforms (Apollo, Blackstone, KKR, Brookfield) functioning as permanent capital vehicles with insurance-linked liabilities, versus a long tail of sub-$5B managers competing for shrinking discretionary LP allocations. For allocators, the question is how to structure exposure that captures the illiquidity premium without the fee drag and misalignment of the prior cycle.
Buyout & Growth Equity
The era of cheap money. Financial engineering masked operational mediocrity.
150-200bps increase on $10B = $150-200M incremental annual interest. Operational alpha is no longer optional.
The mid-market ($500M-$3B enterprise value) has emerged as consensus overweight. Proprietary sourcing remains viable, entry multiples trade at 2-3x EV/EBITDA discount to large-cap, and operational improvement generates measurable alpha. Sector specialists (healthcare services, industrial technology, business services) have outperformed generalists over the past three vintages across Cambridge Associates benchmarks. Add-on strategies require functioning credit markets — the bifurcation between direct lenders (Ares, Blue Owl, Golub) and syndicated markets creates execution risk for GPs without established lending relationships.
The Post-ZIRP Reckoning
Over 40% of Series B+ companies from 2020-2021 vintages have completed down rounds or accepted structured terms. Median DPI for 2021-vintage funds sits below 0.1x against reported TVPIs north of 1.3x. LPs have learned that unrealised paper returns are not liquidity events. AI concentration invites bubble comparisons — but the risk resides in the application layer (thousands of startups valued $50-500M with unproven unit economics), not infrastructure where hyperscalers and Nvidia generate real revenue.
Gulf venture has matured: Shorooq Partners, STV, Wamda Capital deploy $50-200M funds with sector conviction in fintech, logistics tech, and enterprise software. PIF's Sanabil Investments provides sovereign-linked growth capital. Singapore's ecosystem (Vertex Ventures, GIC growth equity) bridges Silicon Valley pricing and Asian growth capital.
The opportunity for Gulf-based LPs and family offices: capture deep-tech innovation while building meaningful allocation to high-growth, lower-entry-multiple venture markets on their doorstep. The geographic rebalancing of VC is the more consequential structural shift than any single technology wave.
Fund Formation & LP Advisory
The Emerging Manager Challenge
First-time funds targeting $500M+ require 18-30 months pre-marketing, verifiable attributable track records (not team track records from prior platforms), institutional-grade back office, and a Day One anchor commitment. Without that anchor, conversion rates below 5%. Re-up rates with existing managers consume 80%+ of LP budgets, leaving emerging managers competing for the residual. Side letter proliferation demands dedicated admin: bespoke fee steps, co-investment rights, MFN clauses, ILPA-compliant transparency.
The GP Stake Market
Blue Owl (formerly Dyal), Petershill (Goldman Sachs), Blackstone Strategic Partners have deployed $50B+ into GP management company equity stakes (10-25% minority positions). GPs monetise fee streams while gaining strategic partners with LP relationships and succession planning. For LPs evaluating GP stakes as an asset class: exposure to contractual recurring fee streams and carried interest optionality across multiple vintages, with lower loss rates than direct fund investment. A secondary market in GP equity is developing its own price discovery.
"The largest and most coveted LPs are systematically reducing dependence on fund structures. The GPs that thrive will offer genuine value-add — not mere capital aggregation."
Sovereign Co-Investment
PIF has built internal sector teams evaluating co-investment with the same rigour as direct investments. Mubadala's long-standing direct capability (GlobalFoundries, AMD) provides a template. GIC and Temasek operate co-investment programmes functionally indistinguishable from proprietary deal origination. The governance challenge: investment committee processes designed for annual fund commitments are poorly suited to 2-4 week co-investment decision timelines. Sovereigns that have adapted delegation frameworks succeed; those that haven't consistently lose allocations to faster-moving peers.
The trend is unmistakable: sovereigns bypass PE funds for large-scale direct investments where target companies prefer single patient capital partners. PIF direct in Lucid Motors and the NEOM ecosystem, Mubadala in technology and energy transition, ADIA in real estate and infrastructure — these represent conviction that for the largest permanent capital pools, the 2-and-20 layer destroys more value than it creates when the sovereign has internal capability to source, execute, and manage directly.
We advise sovereign wealth funds, family offices, and institutional allocators on the full spectrum of private capital engagement — from fund commitment strategy and co-investment programme design to GP selection, emerging manager evaluation, and direct investment structuring. Our presence in Dubai and Singapore positions us within the decision-making corridors of Gulf sovereign capital and Asian institutional growth capital. We do not manage capital; we advise those who deploy it at scale.
Sub-Sectors
Control transaction advisory, management buyout structuring, and value creation planning for mid-market and large-cap acquisitions.
Fund structuring, LPA negotiation, regulatory registration, and the capital raising architecture for first-time and successor funds.
Pre-seed to Series B advisory, founder governance structuring, and the bridge between venture capital and institutional co-investment.
Capital allocation advisory
Fund strategy, co-investment, GP selection — for those who deploy at scale.